China’s eye-support supplement market is becoming part of the country’s preventive-wellness economy
As the country’s consumers are placing greater emphasis on self-care and long-term health maintenance, China’s eye-support supplements market is becoming a more visible part of the country’s preventive-wellness landscape. These supplements are positioned as a daily nutritional support for a range of eye-health needs. The category was expected to reach USD 97.3 million in 2025 […]
Structural shift in consumption: The rise of the silver economy in China
Driven by one of the fastest-aging populations globally, China is entering a demographic turning point that will redefine how businesses, governments, and families think about aging, longevity, and value creation. The silver economy in China has become one of the most structurally important forces reshaping consumption, public policy, and service innovation. Understanding China’s seniors is […]
AI in Chinese healthcare: From medical imaging to AI hospitals
Artificial Intelligence (AI) in Chinese healthcare has seen remarkable growth since implementing the Healthy China 2030 Initiative in 2016. With strong government backing, AI plays a pivotal role in cancer treatment, diagnostic imaging, and telemedicine. The country’s regulatory framework such as Personal Information Protection Law (PIPL), ensures that while healthcare data is protected, it also […]
Digital healthcare in China: Sustained expansion and transformation post-pandemic
Digital healthcare in China is rapidly transforming the healthcare landscape by integrating cutting-edge technologies such as the Internet of Things, big data, and artificial intelligence into medical services, including digitization, standardization, and intelligence of medical consultations and pharmaceutical offerings. The number of online medical users in China increased from 214.8 million in December 2020 to […]
China’s healthcare market: Reform, innovation, and investment shifts
China’s healthcare system is undergoing reforms to improve public hospital operations and integrate advanced technologies. Key changes in 2024 aim to control costs, enhance drug procurement, and open up the medical sector to foreign-owned hospital operations. These changes reflect the government’s efforts to balance rising healthcare demands with fiscal sustainability, all amid China’s rapidly aging […]
China’s pharmaceutical industry: from manufacturing hub to key R&D player
Since joining the World Trade Organization in 2001, China’s pharmaceutical industry has experienced remarkable growth. In 2021, it accounted for 12% of the global pharmaceutical market, second only to the United States, which accounted for a substantial 40% of the world’s total revenue. By 2022, despite challenges from the COVID-19 pandemic, the industry demonstrated resilience, […]
13% of Chinese adults have diabetes: Why the medical industry cannot overlook China’s diabetes treatment market
China’s diabetes treatment market is about to experience a boom, and this piece explains why. For some background, diabetes is a disorder of metabolism that impairs one’s ability to process blood glucose or blood sugar. The pancreas releases insulin to help body store and use the sugar and fat from the food eaten. Diabetes occurs […]
China’s mental health industry on the rise due to prolonged lockdowns
As lockdowns prolong in cities of China like Shanghai, people appear to be less high-spirited due to problems like food shortages and overpriced supplies, which potentially increase the demand for mental health services in China. The impact of long-period home quarantine could be detrimental to mental health, which could potentially lead to a serious mental […]
The crackdown on plastic surgery ads in China: Balancing the beauty economy with surgery scandals and deaths
In September 2021, Chinese state media called for stricter regulations on plastic surgery ads in China, mentioning its excessive pervasiveness and false claims. In the last decade, China’s aesthetic medicine experienced a period of steady growth, driven by rising consumer disposable income, enhanced consumer awareness and the emergence of hedonic values. Chinese aesthetic medicine market […]
China’s biopharmaceutical market prepares for aging boom, but can foreign firms get a piece of the market?
A biopharmaceutical, also known as a biological medical product, refers to any medical drug manufactured in, extracted from, or semi synthesized from biological sources and produced using biotechnology. The biopharmaceutical market is one of the most innovation-intensive industries in the world, investing a great share of capital into research and development compared to any other […]
Linking Chinese healthcare R&D and the Chinese healthcare industry with the rest of the world: China Paradigm transcript #124 with Douglas Corley
This transcript is based on our interview with Douglas Corley, an American healthcare entrepreneur and a bridge between Chinese healthcare R&D and western healthcare institutions. Douglas Corley is the founder and CEO of DHB Global in China. DHB Global provides clients with expert advice on the Chinese healthcare industry. Listen to the full episode of […]
The Economics of Childhood Obesity in China: One in five Chinese children are overweight
In 1995, approximately one in twenty (5.3%) Chinese children were overweight. In 2014, one in five (20.5%) Chinese children were overweight. This makes China’s 2014 childhood overweight prevalence rate about the same as the USA in 1990. On top of this, the growth rate of the childhood overweight prevalence rate in China from 1995 to […]